skip to content

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Pharmacology

Last Updated: November 1, 2016; Last Reviewed: November 1, 2016

Pharmacology
Member Financial Disclosure
Company Relationship
Dooley, Kelly Johns Hopkins University School of Medicine ViiV Healthcare Research Support
George, Jomy  National Institutes of Health None N/A
Kuriakose, Safia National Institutes of Health None N/A
Pau, Alice* National Institutes of Health
None N/A
Peloquin, Charles University of Florida Astra Zeneca Research Support
Jacobus Pharmaceuticals Research Support
Otsuka Advisory Board
Pham, Paul Westview Urgent Care None N/A

* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from November 1, 2014, through November 1, 2016.

Download Guidelines